Healthcare provider profile · identity verified

Danielle Tchoungang, MD

Family Practice · JACKSON, TN · NPI 1881127462

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	287	83
Amlodipine Besylate	Amlodipine Besylate	241	77
Omeprazole	Omeprazole	196	43
Levothyroxine Sodium	Levothyroxine Sodium	170	39
Gabapentin	Gabapentin	168	36
Alendronate Sodium	Alendronate Sodium	153	35
Losartan Potassium	Losartan Potassium	148	40
Pantoprazole Sodium	Pantoprazole Sodium	138	37
Potassium Chloride	Potassium Chloride	127	37
Meloxicam	Meloxicam	116	30
Lisinopril	Lisinopril	114	35
Metformin Hcl	Metformin Hcl	112	32
Rosuvastatin Calcium	Rosuvastatin Calcium	112	35
Hydrochlorothiazide	Hydrochlorothiazide	111	40
Furosemide	Furosemide	107	34
Simvastatin	Simvastatin	107	21
Sertraline Hcl	Sertraline Hcl	86	23
Hydroxyzine Hcl	Hydroxyzine Hcl	84	27
Metoprolol Tartrate	Metoprolol Tartrate	82	23
Buspirone Hcl	Buspirone Hcl	72	13
Clopidogrel	Clopidogrel Bisulfate	68	20
Fluticasone Propionate	Fluticasone Propionate	65	23
Ozempic	Semaglutide	60	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	15
Duloxetine Hcl	Duloxetine Hcl	56	17
Metformin Hcl Er	Metformin Hcl	55	17
Jardiance	Empagliflozin	54	suppressed
Famotidine	Famotidine	51	17
Metoprolol Succinate	Metoprolol Succinate	51	20
Alprazolam	Alprazolam	50	suppressed
Eliquis	Apixaban	49	16
Tizanidine Hcl	Tizanidine Hcl	48	suppressed
Trazodone Hcl	Trazodone Hcl	48	19
Allopurinol	Allopurinol	47	12
Albuterol Sulfate Hfa	Albuterol Sulfate	46	20
Diclofenac Sodium	Diclofenac Sodium	46	12
Mounjaro	Tirzepatide	46	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	45	suppressed
Glimepiride	Glimepiride	45	13
Tamsulosin Hcl	Tamsulosin Hcl	44	12
Carvedilol	Carvedilol	42	16
Chlorthalidone	Chlorthalidone	39	13
Mirtazapine	Mirtazapine	38	suppressed
Montelukast Sodium	Montelukast Sodium	38	14
Spironolactone	Spironolactone	38	12
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	35	suppressed
Lactulose	Lactulose	34	suppressed
Tramadol Hcl	Tramadol Hcl	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	12
Ondansetron Odt	Ondansetron	33	12
Chlorhexidine Gluconate	Chlorhexidine Gluconate	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Meclizine Hcl	Meclizine Hcl	28	12
Clonidine Hcl	Clonidine Hcl	27	suppressed
Linzess	Linaclotide	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Constulose	Lactulose	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Ramipril	Ramipril	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Naproxen	Naproxen	21	suppressed
Prednisone	Prednisone	21	18
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	17
Celecoxib	Celecoxib	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	19
Ketoconazole	Ketoconazole	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Loperamide	Loperamide Hcl	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Mometasone Furoate	Mometasone Furoate	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	14
Westab Plus	Pnv,calcium 72/Iron/Folic Acid	17	suppressed
Atenolol	Atenolol	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Primidone	Primidone	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Megestrol Acetate	Megestrol Acetate	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Baclofen	Baclofen	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Colchicine	Colchicine	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Restasis Multidose	Cyclosporine	12	suppressed
Torsemide	Torsemide	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Haloperidol	Haloperidol	11	suppressed
Nystatin	Nystatin	11	suppressed
Praluent Pen	Alirocumab	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error